top of page
Drug discovery and DMPK expert with over 23 years in the pharma, biotech and CRO industry
Extensive neuroscience DMPK experience at MSD, AstraZeneca UK and Shire UK
Previous experience also includes Head of DMPK at Sygnature Discovery, Head of Preclinical Development at Chronos Therapeutics and COO at both Pandeia Therapeutics and Round Earth Therapeutics
Timothy Schulz-Utermoehl, PhD
Head of DMPK
bottom of page